We continue on our journey through early stage breast cancer, this time turning our attention to HER2+ disease. There is a lot of data in this episode, as you will both hear and see. To make this easier, we highlight key takeaways to make understanding this even easier.
Content:
- What is HER2?
- Discovery of trastuzumab
- Data for use of trastuzumab in adjuvant and neoadjuvant setting
- Data for use of pertuzumab in adjuvant and neoadjuvant setting
- Data and use of trastuzumab emtansine (TDM-1) in the adjuvant setting
- Management of HER2+ stage I breast cancer
- Highlights of key trials that shape the paradigm of management
- Our approach to management
** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes
Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!
Twitter: @TheFellowOnCall
Instagram: @TheFellowOnCall
Listen in on: Apple Podcast, Spotify, and Google Podcast
